Angiogenesis revisited - Role and therapeutic potential of targeting endothelial metabolism

Journal of Cell Science

Volumn 127, Issue 20, 2014, Pages 4331-4341

  Stapor, Peter ^a,b   Wang, Xingwu ^a,b   Goveia, Jermaine ^a,b   Moens, Stijn ^a,b   Carmeliet, Peter ^a,b  

^a Vesalius Research Center   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Angiogenesis; Anti angiogenesis therapy; Glycolysis; Metabolism

Indexed keywords

AMINO ACID; ANGIOGENIC FACTOR; FATTY ACID; GLYCOGEN; HEXOSAMINE; POLYOL; 6 PHOSPHOFRUCTO 2 KINASE; ADENOSINE TRIPHOSPHATE; ANGIOGENESIS INHIBITOR; PFKFB3 PROTEIN, HUMAN;

AMINO ACID METABOLISM; ANGIOGENESIS; ANTIANGIOGENIC THERAPY; BIOSYNTHESIS; CELL METABOLISM; ENDOTHELIUM CELL; FATTY ACID OXIDATION; GLYCOGEN METABOLISM; GLYCOLYSIS; HUMAN; METABOLIC REGULATION; MITOCHONDRION; NOTE; OXIDATIVE PHOSPHORYLATION; PENTOSE PHOSPHATE CYCLE; PHENOTYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIUM;

ADENOSINE TRIPHOSPHATE; ANGIOGENESIS INHIBITORS; ANIMALS; ENDOTHELIUM, VASCULAR; GLYCOLYSIS; HUMANS; MOLECULAR TARGETED THERAPY; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOFRUCTOKINASE-2;

EID: 84918493695     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.153908     Document Type: Note

References (149)

1. Adams, R. H. and Alitalo, K. (2007). Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8, 464-478.
2. Ali, M. H., Pearlstein, D. P., Mathieu, C. E. and Schumacker, P. T. (2004). Mitochondrial requirement for endothelial responses to cyclic strain: implications for mechanotransduction. Am. J. Physiol. 287, L486-L496.
3. Almeida, A., Bolaños, J. P. and Moncada, S. (2010). E3 ubiquitin ligase APC/CCdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc. Natl. Acad. Sci. USA 107, 738-741.
4. Amemiya, T. (1983). Glycogen metabolism in the capillary endothelium. Electron histochemical study of glycogen synthetase and phosphorylase in the pecten capillary of the chick. Acta Histochem. 73, 93-96.
5. Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B., Jiang, J. K., Shen, M., Bellinger, G., Sasaki, A. T., Locasale, J. W., Auld, D. S. et al. (2011). Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334, 1278-1283.
6. Arany, Z., Foo, S. Y., Ma, Y., Ruas, J. L., Bommi-Reddy, A., Girnun, G., Cooper, M., Laznik, D., Chinsomboon, J., Rangwala, S. M. et al. (2008). HIFindependent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 451, 1008-1012.
7. Artwohl, M., Brunmair, B., Fürnsinn, C., Hölzenbein, T., Rainer, G., Freudenthaler, A., Porod, E. M., Huttary, N. and Baumgartner-Parzer, S. M. (2007). Insulin does not regulate glucose transport and metabolism in human endothelium. Eur. J. Clin. Invest. 37, 643-650.
8. Augustin, H. G., Koh, G. Y., Thurston, G. and Alitalo, K. (2009). Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 10, 165-177.
9. Benedito, R., Roca, C., Sörensen, I., Adams, S., Gossler, A., Fruttiger, M. and Adams, R. H. (2009). The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137, 1124-1135.
10. Bentley, K., Mariggi, G., Gerhardt, H. and Bates, P. A. (2009). Tipping the balance: robustness of tip cell selection, migration and fusion in angiogenesis. PLOS Comput. Biol. 5, e1000549.
11. Blake, R. and Trounce, I. A. (2013). Mitochondrial dysfunction and complications associated with diabetes. Biochim. Biophys. Acta.
12. Blouin, A., Bolender, R. P. and Weibel, E. R. (1977). Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J. Cell Biol. 72, 441-455.
13. Brown, G. C. and Cooper, C. E. (1994). Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 356, 295-298.
14. Buchwald, P. (2011). A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets. Theor. Biol. Med. Model. 8, 20.
15. Cai, H. (2005). Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc. Res. 68, 26-36.
16. Cappai, G., Songini, M., Doria, A., Cavallerano, J. D. and Lorenzi, M. (2011). Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase. Diabetologia 54, 1539-1542.
17. Carmeliet, P. and Jain, R. K. (2011). Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug Discov. 10, 417-427.
18. Carmeliet, P., Wong, B. W. and De Bock, K. (2012). Treating diabetes by blocking a vascular growth factor. Cell Metab. 16, 553-555.
19. Chalkiadaki, A. and Guarente, L. (2012). Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat. Rev. Endocrinol. 8, 287-296.
20. Chatterjee, S. and Fisher, A. B. (2014). Mechanotransduction: forces, sensors and redox signaling. Antioxid. Redox Signal. 20, 868-871.
21. Chua, C. C., Hamdy, R. C. and Chua, B. H. (1998). Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic. Biol. Med. 25, 891-897.
22. Clementi, E., Brown, G. C., Feelisch, M. and Moncada, S. (1998). Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Natl. Acad. Sci. USA 95, 7631-7636.
23. Croci, D. O., Cerliani, J. P., Dalotto-Moreno, T., Méndez-Huergo, S. P., Mascanfroni, I. D., Dergan-Dylon, S., Toscano, M. A., Caramelo, J. J., García-Vallejo, J. J., Ouyang, J. et al. (2014). Glycosylation-dependent lectinreceptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell 156, 744-758.
24. Cucullo, L., Hossain, M., Puvenna, V., Marchi, N. and Janigro, D. (2011). The role of shear stress in Blood-Brain Barrier endothelial physiology. BMC Neurosci. 12, 40.
25. Culic, O., Gruwel, M. L. and Schrader, J. (1997). Energy turnover of vascular endothelial cells. Am. J. Physiol. 273, C205-C213.
26. Dagher, Z., Ruderman, N., Tornheim, K. and Ido, Y. (1999). The effect of AMPactivated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 265, 112-115.
27. Dagher, Z., Ruderman, N., Tornheim, K. and Ido, Y. (2001). Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells. Circ. Res. 88, 1276-1282.
28. Davidson, S. M. and Duchen, M. R. (2007). Endothelial mitochondria: contributing to vascular function and disease. Circ. Res. 100, 1128-1141.
29. De Bock, K., Georgiadou, M. and Carmeliet, P. (2013a). Role of endothelial cell metabolism in vessel sprouting. Cell Metab. 18, 634-647.
30. De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B. W., Cantelmo, A. R., Quaegebeur, A., Ghesquière, B., Cauwenberghs, S., Eelen, G. et al. (2013b). Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154, 651-663.
31. De Saedeleer, C. J., Copetti, T., Porporato, P. E., Verrax, J., Feron, O. and Sonveaux, P. (2012). Lactate activates HIF-1 in oxidative but not in Warburgphenotype human tumor cells. PLoS ONE 7, e46571.
32. DeBerardinis, R. J. and Cheng, T. (2010). Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29, 313-324.
33. Delgado, T., Carroll, P. A., Punjabi, A. S., Margineantu, D., Hockenbery, D. M. and Lagunoff, M. (2010). Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc. Natl. Acad. Sci. USA 107, 10696-10701.
34. Denton, R. M. and McCormack, J. G. (1990). Ca2+ as a second messenger within mitochondria of the heart and other tissues. Annu. Rev. Physiol. 52, 451-466.
35. Dikalov, S. I., Nazarewicz, R. R., Bikineyeva, A., Hilenski, L., Lassègue, B., Griendling, K. K., Harrison, D. G. and Dikalova, A. E. (2014). Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxid. Redox Signal. 20, 281-294.
36. Dobrina, A. and Rossi, F. (1983). Metabolic properties of freshly isolated bovine endothelial cells. Biochim. Biophys. Acta 762, 295-301.
37. Dranka, B. P., Hill, B. G. and Darley-Usmar, V. M. (2010). Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species. Free Radic. Biol. Med. 48, 905-914.
38. Eijkelenboom, A. and Burgering, B. M. (2013). FOXOs: signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 14, 83-97.
39. Eilken, H. M. and Adams, R. H. (2010). Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr. Opin. Cell Biol. 22, 617-625.
40. Elmasri, H., Karaaslan, C., Teper, Y., Ghelfi, E., Weng, M., Ince, T. A., Kozakewich, H., Bischoff, J. and Cataltepe, S. (2009). Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J. 23, 3865-3873.
41. Ferrara, N. and Kerbel, R. S. (2005). Angiogenesis as a therapeutic target. Nature 438, 967-974.
42. Fijalkowska, I., Xu, W., Comhair, S. A., Janocha, A. J., Mavrakis, L. A., Krishnamachary, B., Zhen, L., Mao, T., Richter, A., Erzurum, S. C. et al. (2010). Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells. Am. J. Pathol. 176, 1130-1138.
43. Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186.
44. Fraccaroli, A., Franco, C. A., Rognoni, E., Neto, F., Rehberg, M., Aszodi, A., Wedlich-Söldner, R., Pohl, U., Gerhardt, H. and Montanez, E. (2012). Visualization of endothelial actin cytoskeleton in the mouse retina. PLoS ONE 7, e47488.
45. Fraisl, P., Mazzone, M., Schmidt, T. and Carmeliet, P. (2009). Regulation of angiogenesis by oxygen and metabolism. Dev. Cell 16, 167-179.
46. Fu, Z. J., Li, S. Y., Kociok, N., Wong, D., Chung, S. K. and Lo, A. C. (2012). Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 53, 5698-5712.
47. Fu, L., Huang, M. and Chen, S. (2013). Primary carnitine deficiency and cardiomyopathy. Korean Circ. J. 43, 785-792.
48. Fülöp, N., Marchase, R. B. and Chatham, J. C. (2007). Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc. Res. 73, 288-297.
49. Furuyama, T., Kitayama, K., Shimoda, Y., Ogawa, M., Sone, K., Yoshida-Araki, K., Hisatsune, H., Nishikawa, S., Nakayama, K., Nakayama, K. et al. (2004). Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 279, 34741-34749.
50. Gatenby, R. A. and Gillies, R. J. (2004). Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891-899.
51. Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D. et al. (2003). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163-1177.
52. Ghelfi, E., Yu, C. W., Elmasri, H., Terwelp, M., Lee, C. G., Bhandari, V., Comhair, S. A., Erzurum, S. C., Hotamisligil, G. S., Elias, J. A. et al. (2013). Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma. Am. J. Pathol. 182, 1425-1433.
53. Giacco, F. and Brownlee, M. (2010). Oxidative stress and diabetic complications. Circ. Res. 107, 1058-1070.
54. Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D. and Jain, R. K. (2011). Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. 91, 1071-1121.
55. Granchi, C. and Minutolo, F. (2012). Anticancer agents that counteract tumor glycolysis. ChemMedChem 7, 1318-1350.
56. Groschner, L. N., Waldeck-Weiermair, M., Malli, R. and Graier, W. F. (2012). Endothelial mitochondria-less respiration, more integration. Pflugers Arch. 464, 63-76.
57. Guarani, V. and Potente, M. (2010). SIRT1-a metabolic sensor that controls blood vessel growth. Curr. Opin. Pharmacol. 10, 139-145.
58. Häberle, J., Görg, B., Rutsch, F., Schmidt, E., Toutain, A., Benoist, J. F., Gelot, A., Suc, A. L., Höhne, W., Schliess, F. et al. (2005). Congenital glutamine deficiency with glutamine synthetase mutations. N. Engl. J. Med. 353, 1926-1933.
59. Hagberg, C. E., Mehlem, A., Falkevall, A., Muhl, L., Fam, B. C., Ortsäter, H., Scotney, P., Nyqvist, D., Samén, E., Lu, L. et al. (2012). Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes. Nature 490, 426-430.
60. Harjes, U., Bensaad, K. and Harris, A. L. (2012). Endothelial cell metabolism and implications for cancer therapy. Br. J. Cancer 107, 1207-1212.
61. Héliès-Toussaint, C., Gambert, S., Roller, P., Tricot, S., Lacour, B. and Grynberg, A. (2006). Lipid metabolism in human endothelial cells. Biochim. Biophys. Acta 1761, 765-774.
62. Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R. A., Warnholtz, A. et al. (2001). Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88, E14-E22.
63. Hinshaw, D. B. and Burger, J. M. (1990). Protective effect of glutamine on endothelial cell ATP in oxidant injury. J. Surg. Res. 49, 222-227.
64. Huang, Y., Lei, L., Liu, D., Jovin, I., Russell, R., Johnson, R. S., Di Lorenzo, A. and Giordano, F. J. (2012). Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1α-dependent function. Proc. Natl. Acad. Sci. USA 109, 17478-17483.
65. Hunt, T. K., Aslam, R. S., Beckert, S., Wagner, S., Ghani, Q. P., Hussain, M. Z., Roy, S. and Sen, C. K. (2007). Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxid. Redox Signal. 9, 1115-1124.
66. Jakobsson, L., Franco, C. A., Bentley, K., Collins, R. T., Ponsioen, B., Aspalter, I. M., Rosewell, I., Busse, M., Thurston, G., Medvinsky, A. et al. (2010). Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell Biol. 12, 943-953.
67. Jeon, S. M., Chandel, N. S. and Hay, N. (2012). AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485, 661-665.
68. Jeppesen, J. and Kiens, B. (2012). Regulation and limitations to fatty acid oxidation during exercise. J. Physiol. 590, 1059-1068.
69. Jongkind, J. F., Verkerk, A. and Baggen, R. G. (1989). Glutathione metabolism of human vascular endothelial cells under peroxidative stress. Free Radic. Biol. Med. 7, 507-512.
70. Kluge, M. A., Fetterman, J. L. and Vita, J. A. (2013). Mitochondria and endothelial function. Circ. Res. 112, 1171-1188.
71. Knapp, A., Czech, U., Góralska, J., Sliwa, A., Gruca, A., Kieć-Wilk, B., Awsiuk, M., Thiele, C., Dudek, W. and Dembińska-Kieć, A. (2012). Influence of fatty acids on mitochondrial metabolism of adipocyte progenitors and endothelial cells. Arch. Physiol. Biochem. 118, 128-134.
72. Koziel, A., Woyda-Ploszczyca, A., Kicinska, A. and Jarmuszkiewicz, W. (2012). The influence of high glucose on the aerobic metabolism of endothelial EA.hy926 cells. Pflugers Arch. 464, 657-669.
73. Krützfeldt, A., Spahr, R., Mertens, S., Siegmund, B. and Piper, H. M. (1990). Metabolism of exogenous substrates by coronary endothelial cells in culture. J. Mol. Cell. Cardiol. 22, 1393-1404.
74. Laczy, B., Hill, B. G., Wang, K., Paterson, A. J., White, C. R., Xing, D., Chen, Y. F., Darley-Usmar, V., Oparil, S. and Chatham, J. C. (2009). Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. Am. J. Physiol. 296, H13-H28.
75. Lamalice, L., Le Boeuf, F. and Huot, J. (2007). Endothelial cell migration during angiogenesis. Circ. Res. 100, 782-794.
76. Lee, J., Giordano, S. and Zhang, J. (2012). Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441, 523-540.
77. Leopold, J. A., Walker, J., Scribner, A. W., Voetsch, B., Zhang, Y. Y., Loscalzo, A. J., Stanton, R. C. and Loscalzo, J. (2003a). Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J. Biol. Chem. 278, 32100-32106.
78. Leopold, J. A., Zhang, Y. Y., Scribner, A. W., Stanton, R. C. and Loscalzo, J. (2003b). Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler. Thromb. Vasc. Biol. 23, 411-417.
79. Li, J. M. and Shah, A. M. (2004). Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am. J. Physiol. 287, R1014-R1030.
80. Liu, Y., Zhao, H., Li, H., Kalyanaraman, B., Nicolosi, A. C. and Gutterman, D. D. (2003). Mitochondrial sources of H2O2 generation play a key role in flowmediated dilation in human coronary resistance arteries. Circ. Res. 93, 573-580.
81. Locasale, J. W. and Cantley, L. C. (2011). Metabolic flux and the regulation of mammalian cell growth. Cell Metab. 14, 443-451.
82. Luo, B., Soesanto, Y. and McClain, D. A. (2008). Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28, 651-657.
83. Makino, A., Scott, B. T. and Dillmann, W. H. (2010). Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia 53, 1783-1794.
84. Mallat, Z. and Tedgui, A. (2000). Apoptosis in the vasculature: mechanisms and functional importance. Br. J. Pharmacol. 130, 947-962.
85. Malli, R., Frieden, M., Osibow, K., Zoratti, C., Mayer, M., Demaurex, N. and Graier, W. F. (2003). Sustained Ca2+ transfer across mitochondria is Essential for mitochondrial Ca2+ buffering, sore-operated Ca2+ entry, and Ca2+ store refilling. J. Biol. Chem. 278, 44769-44779.
86. Mann, G. E., Yudilevich, D. L. and Sobrevia, L. (2003). Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol. Rev. 83, 183-252.
87. Markowska, A. I., Jefferies, K. C. and Panjwani, N. (2011). Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells. J. Biol. Chem. 286, 29913-29921.
88. Merchan, J. R., Kovács, K., Railsback, J. W., Kurtoglu, M., Jing, Y., Piña, Y., Gao, N., Murray, T. G., Lehrman, M. A. and Lampidis, T. J. (2010). Antiangiogenic activity of 2-deoxy-D-glucose. PLoS ONE 5, e13699.
89. Mertens, S., Noll, T., Spahr, R., Krützfeldt, A. and Piper, H. M. (1990). Energetic response of coronary endothelial cells to hypoxia. Am. J. Physiol. 258, H689-H694.
90. Metallo, C. M. and Vander Heiden, M. G. (2013). Understanding metabolic regulation and its influence on cell physiology. Mol. Cell 49, 388-398.
91. Mouilleron, S. and Golinelli-Pimpaneau, B. (2007). Conformational changes in ammonia-channeling glutamine amidotransferases. Curr. Opin. Struct. Biol. 17, 653-664.
92. Mount, P. F., Lane, N., Venkatesan, S., Steinberg, G. R., Fraser, S. A., Kemp, B. E. and Power, D. A. (2008). Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK. Atherosclerosis 200, 28-36.
93. Mullen, A. R. and DeBerardinis, R. J. (2012). Genetically-defined metabolic reprogramming in cancer. Trends Endocrinol. Metab. 23, 552-559.
94. Muñoz-Chápuli, R., Carmona, R., Guadix, J. A., Macías, D. and Pérez-Pomares, J. M. (2005). The origin of the endothelial cells: an evo-devo approach for the invertebrate/vertebrate transition of the circulatory system. Evol. Dev. 7, 351-358.
95. Murray, B. and Wilson, D. J. (2001). A study of metabolites as intermediate effectors in angiogenesis. Angiogenesis 4, 71-77.
96. Nazarewicz, R. R., Dikalova, A. E., Bikineyeva, A. and Dikalov, S. I. (2013). Nox2 as a potential target of mitochondrial superoxide and its role in endothelial oxidative stress. Am. J. Physiol. 305, H1131-H1140.
97. Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C. et al. (2009). Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136, 521-534.
98. Obrosova, I. G. and Kador, P. F. (2011). Aldose reductase/polyol inhibitors for diabetic retinopathy. Curr. Pharm. Biotechnol. 12, 373-385.
99. Oellerich, M. F. and Potente, M. (2012). FOXOs and sirtuins in vascular growth, maintenance, and aging. Circ. Res. 110, 1238-1251.
100. Okuno, Y., Nakamura-Ishizu, A., Otsu, K., Suda, T. and Kubota, Y. (2012). Pathological neoangiogenesis depends on oxidative stress regulation by ATM. Nat. Med. 18, 1208-1216.
101. Pan, S., World, C. J., Kovacs, C. J. and Berk, B. C. (2009). Glucose 6-phosphate dehydrogenase is regulated through c-Src-mediated tyrosine phosphorylation in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29, 895-901.
102. Pangare, M. and Makino, A. (2012). Mitochondrial function in vascular endothelial cell in diabetes. J. Smooth Muscle Res. 48, 1-26.
103. Parra-Bonilla, G., Alvarez, D. F., Al-Mehdi, A. B., Alexeyev, M. and Stevens, T. (2010). Critical role for lactate dehydrogenase A in aerobic glycolysis that sustains pulmonary microvascular endothelial cell proliferation. Am. J. Physiol. 299, L513-L522.
104. Pearlstein, D. P., Ali, M. H., Mungai, P. T., Hynes, K. L., Gewertz, B. L. and Schumacker, P. T. (2002). Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia. Arterioscler. Thromb. Vasc. Biol. 22, 566-573.
105. Peters, K., Kamp, G., Berz, A., Unger, R. E., Barth, S., Salamon, A., Rychly, J. and Kirkpatrick, C. J. (2009). Changes in human endothelial cell energy metabolic capacities during in vitro cultivation. The role of 'aerobic glycolysis' and proliferation. Cell. Physiol. Biochem. 24, 483-492.
106. Phng, L.-K., Potente, M., Leslie, J. D., Babbage, J., Nyqvist, D., Lobov, I., Ondr, J. K., Rao, S., Lang, R. A., Thurston, G. et al. (2009). Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev. Cell 16, 70-82.
107. Pike, L. S., Smift, A. L., Croteau, N. J., Ferrick, D. A. and Wu, M. (2011). Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim. Biophys. Acta 1807, 726-734.
108. Polet, F. and Feron, O. (2013). Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force. J. Intern. Med. 273, 156-165.
109. Pollard, T. D. (2007). Regulation of actin filament assembly by Arp2/3 complex and formins. Annu. Rev. Biophys. Biomol. Struct. 36, 451-477.
110. Potente, M., Ghaeni, L., Baldessari, D., Mostoslavsky, R., Rossig, L., Dequiedt, F., Haendeler, J., Mione, M., Dejana, E., Alt, F. W. et al. (2007). SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 21, 2644-2658.
111. Potente, M., Gerhardt, H. and Carmeliet, P. (2011). Basic and therapeutic aspects of angiogenesis. Cell 146, 873-887.
112. Qi, L., Qi, Q., Prudente, S., Mendonca, C., Andreozzi, F., di Pietro, N., Sturma, M., Novelli, V., Mannino, G. C., Formoso, G. et al. (2013). Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA 310, 821-828.
113. Quintero, M., Colombo, S. L., Godfrey, A. and Moncada, S. (2006). Mitochondria as signaling organelles in the vascular endothelium. Proc. Natl. Acad. Sci. USA 103, 5379-5384.
114. Raaz, U., Toh, R., Maegdefessel, L., Adam, M., Nakagami, F., Emrich, F. C., Spin, J. M. and Tsao, P. S. (2014). Hemodynamic regulation of reactive oxygen species: implications for vascular diseases. Antioxid. Redox Signal. 20, 914-928.
115. Raez, L. E., Papadopoulos, K., Ricart, A. D., Chiorean, E. G., Dipaola, R. S., Stein, M. N., Rocha Lima, C. M., Schlesselman, J. J., Tolba, K., Langmuir, V. K. et al. (2013). A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother. Pharmacol. 71, 523-530.
116. Real-Hohn, A., Zancan, P., Da Silva, D., Martins, E. R., Salgado, L. T., Mermelstein, C. S., Gomes, A. M. and Sola-Penna, M. (2010). Filamentous actin and its associated binding proteins are the stimulatory site for 6-phosphofructo-1-kinase association within the membrane of human erythrocytes. Biochimie 92, 538-544.
117. Reihill, J. A., Ewart, M. A. and Salt, I. P. (2011). The role of AMP-activated protein kinase in the functional effects of vascular endothelial growth factor-A and-B in human aortic endothelial cells. Vasc. Cell 3, 9.
118. Roach, P. J., Depaoli-Roach, A. A., Hurley, T. D. and Tagliabracci, V. S. (2012). Glycogen and its metabolism: some new developments and old themes. Biochem. J. 441, 763-787.
119. Romero, S., Didry, D., Larquet, E., Boisset, N., Pantaloni, D. and Carlier, M. F. (2007). How ATP hydrolysis controls filament assembly from profilin-actin: implication for formin processivity. J. Biol. Chem. 282, 8435-8445.
120. Ruiz-Ginés, J. A., López-Ongil, S., González-Rubio, M., González-Santiago, L., Rodríguez-Puyol, M. and Rodríguez-Puyol, D. (2000). Reactive oxygen species induce proliferation of bovine aortic endothelial cells. J. Cardiovasc. Pharmacol. 35, 109-113.
121. Sawada, N., Jiang, A., Takizawa, F., Safdar, A., Manika, A., Tesmenitsky, Y., Kang, K. T., Bischoff, J., Kalwa, H., Sartoretto, J. L. et al. (2014). Endothelial PGC-1α mediates vascular dysfunction in diabetes. Cell Metab. 19, 246-258.
122. Schoors, S., Cantelmo, A. R., Georgiadou, M., Stapor, P., Wang, X., Quaegebeur, A., Cauwenberghs, S., Wong, B. W., Bifari, F., Decimo, I. et al. (2014a). Incomplete and transitory decrease of glycolysis: a new paradigm for anti-angiogenic therapy? Cell Cycle 13, 16-22.
123. Schoors, S., De Bock, K., Cantelmo, A. R., Georgiadou, M., Ghesquière, B., Cauwenberghs, S., Kuchnio, A., Wong, B. W., Quaegebeur, A., Goveia, J. et al. (2014b). Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. Cell Metab. 19, 37-48.
124. Sekhar, R. V., Patel, S. G., Guthikonda, A. P., Reid, M., Balasubramanyam, A., Taffet, G. E. and Jahoor, F. (2011). Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am. J. Clin. Nutr. 94, 847-853.
125. Shenouda, S. M., Widlansky, M. E., Chen, K., Xu, G., Holbrook, M., Tabit, C. E., Hamburg, N. M., Frame, A. A., Caiano, T. L., Kluge, M. A. et al. (2011). Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation 124, 444-453.
126. Spahr, R., Krützfeldt, A., Mertens, S., Siegmund, B. and Piper, H. M. (1989). Fatty acids are not an important fuel for coronary microvascular endothelial cells. Mol. Cell. Biochem. 88, 59-64.
127. Spolarics, Z. and Spitzer, J. J. (1993). Augmented glucose use and pentose cycle activity in hepatic endothelial cells after in vivo endotoxemia. Hepatology 17, 615-620.
128. Spolarics, Z. and Wu, J. X. (1997). Role of glutathione and catalase in H2O2 detoxification in LPS-activated hepatic endothelial and Kupffer cells. Am. J. Physiol. 273, G1304-G1311.
129. Tammali, R., Reddy, A. B., Srivastava, S. K. and Ramana, K. V. (2011). Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo. Angiogenesis 14, 209-221.
130. Tennant, D. A., Durán, R. V. and Gottlieb, E. (2010). Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer 10, 267-277.
131. Trudeau, K., Molina, A. J., Guo, W. and Roy, S. (2010). High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathy. Am. J. Pathol. 177, 447-455.
132. Unterluggauer, H., Mazurek, S., Lener, B., Hütter, E., Eigenbrodt, E., Zwerschke, W. and Jansen-Dürr, P. (2008). Premature senescence of human endothelial cells induced by inhibition of glutaminase. Biogerontology 9, 247-259.
133. Vander Heiden, M. G., Chandel, N. S., Williamson, E. K., Schumacker, P. T. and Thompson, C. B. (1997). Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627-637.
134. Vander Heiden, M. G., Lunt, S. Y., Dayton, T. L., Fiske, B. P., Israelsen, W. J., Mattaini, K. R., Vokes, N. I., Stephanopoulos, G., Cantley, L. C., Metallo, C. M. et al. (2011). Metabolic pathway alterations that support cell proliferation. Cold Spring Harb. Symp. Quant. Biol. 76, 325-334.
135. Vaux, D. L. (2011). Apoptogenic factors released from mitochondria. Biochim. Biophys. Acta 1813, 546-550.
136. Végran, F., Boidot, R., Michiels, C., Sonveaux, P. and Feron, O. (2011). Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Res. 71, 2550-2560.
137. Vizán, P., Sánchez-Tena, S., Alcarraz-Vizán, G., Soler, M., Messeguer, R., Pujol, M. D., Lee, W. N. and Cascante, M. (2009). Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets. Carcinogenesis 30, 946-952.
138. Vo, T. D., Greenberg, H. J. and Palsson, B. O. (2004). Reconstruction and functional characterization of the human mitochondrial metabolic network based on proteomic and biochemical data. J. Biol. Chem. 279, 39532-39540.
139. Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J. et al. (2011a). The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871-882.
140. Wang, Y., Zang, Q. S., Liu, Z., Wu, Q., Maass, D., Dulan, G., Shaul, P. W., Melito, L., Frantz, D. E., Kilgore, J. A. et al. (2011b). Regulation of VEGFinduced endothelial cell migration by mitochondrial reactive oxygen species. Am. J. Physiol. 301, C695-C704.
141. Wood, P. G. and Gillespie, J. I. (1998). Evidence for mitochondrial Ca(2+)-induced Ca2+ release in permeabilised endothelial cells. Biochem. Biophys. Res. Commun. 246, 543-548.
142. Wright, G. L., Maroulakou, I. G., Eldridge, J., Liby, T. L., Sridharan, V., Tsichlis, P. N. and Muise-Helmericks, R. C. (2008). VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase. FASEB J. 22, 3264-3275.
143. Wu, G., Haynes, T. E., Li, H., Yan, W. and Meininger, C. J. (2001). Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis. Biochem. J. 353, 245-252.
144. Yeh, W. L., Lin, C. J. and Fu, W. M. (2008). Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol. Pharmacol. 73, 170-177.
145. Yogurtcu, O. N., Kim, J. S. and Sun, S. X. (2012). A mechanochemical model of actin filaments. Biophys. J. 103, 719-727.
146. Zanetti, M., Katusic, Z. S. and O'Brien, T. (2002). Adenoviral-mediated overexpression of catalase inhibits endothelial cell proliferation. Am. J. Physiol. 283, H2620-H2626.
147. Zhang, D. X. and Gutterman, D. D. (2007). Mitochondrial reactive oxygen speciesmediated signaling in endothelial cells. Am. J. Physiol. 292, H2023-H2031.
148. Zhang, Z., Apse, K., Pang, J. and Stanton, R. C. (2000). High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J. Biol. Chem. 275, 40042-40047.
149. Zhang, Z., Yang, Z., Zhu, B., Hu, J., Liew, C. W., Zhang, Y., Leopold, J. A., Handy, D. E., Loscalzo, J. and Stanton, R. C. (2012). Increasing glucose 6-phosphate dehydrogenase activity restores redox balance in vascular endothelial cells exposed to high glucose. PLoS ONE 7, e49128.